Kidswell Bio Corporation (TYO:4584)

Kidswell Bio Revenue

In the fiscal year ending March 31, 2026, Kidswell Bio had annual revenue of 6.59B JPY with 29.65% growth. Kidswell Bio had revenue of 1.57B in the quarter ending March 31, 2026, a decrease of -23.26%.

• Revenue: 6.59B
• Revenue Growth: +29.65%
• P/S Ratio: 1.11
• Revenue / Employee: 178.08M
• Employees: 37
• Market Cap: 7.34B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	6.59B	1.51B	29.65%
Mar 31, 2025	5.08B	3.51B	223.90%
Mar 31, 2022	1.57B	573.00M	57.53%
Mar 31, 2021	996.00M	-81.00M	-7.52%
Mar 31, 2020	1.08B	55.30M	5.41%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error